Patients with Crohn’s fistula may benefit from therapy with autologous adipose-derived stem cells (ASCs), according to the results of a phase 2 clinical trial conducted by five medical institutions in collaboration ... Read more
TiGenix, an advanced biotechnological company committed to developing and marketing new therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) for autoimmune and inflammatory diseases, together with Lonza, a leading and global company of ... Read more
Scientists recently made a significant breakthrough in the field of gastroenterological research and development by successfully creating the first three-dimensional human stomach tissue, which can serve as a miniature stomach model to ... Read more
